International Conference on Head and Neck Oncology

ICHNO

16th Mar – 17th Mar 2027 Tokyo, Japan

Official Invitation Letter Available

An official invitation letter will be provided upon successful registration for your participation in the conference.

Benefits of Registering as Listener

Access to All Conference Sessions

Plenary, keynote and parallel sessions

Networking Opportunities

Connect with global educators & researchers

Certificate of Participation

Digital certificate of participation

Invitation Letter Support

Official invitation letter after successful registration

Conference Kit / Digital Materials

E-proceedings & resource materials

Access to Keynote Sessions

Learn from leading experts & scholars

Credit Card

Debit Card

Net Banking

Cash Card

Unified Payments

Select Registration Mode

Standard / Physical Participation USD

Join us on-site for keynotes, talks, workshops, networking, conference kit and certificate.

Virtual Participation USD

Participate online via live streaming. Includes live access to all sessions, digital materials and certificate.

Participant Details

Full Name *

Email Address *

Mobile Number with Country Code *

City *

State *

Country *

Zip / Postal Code *

Address *

Coupon Code

10% OFF on Registration.
Use Coupon Code → EARLY10

Terms & Condition

I agree to the Terms & Conditions and Refund & Cancellation Policy.

Registration Summary

Conference ICHNO

Date 16th Mar – 17th Mar 2027

Location Tokyo, Japan

Participation Type Listener

Organizer Science Leagues

Registration Mode Standard / Physical

Registration Fee USD 0.00

Bank Convenience Charges (5.8%)i USD 0.00

Calculated based on 5.8% of the registration fee

Discount USD 0.00

Total Payable USD 0.00

100% Secure Payment

Your payment information is encrypted and processed securely.

Conference Session Tracks

Aligned with UN Sustainable Development Goals

The conference's session tracks effectively support the following SDGs.

01 Advancements in Head and Neck Oncology: Basic Science and Biomarkers +

This track will explore the latest discoveries in basic science related to head and neck oncology, focusing on the identification and validation of biomarkers. Participants will discuss how these advancements can inform clinical practice and improve patient outcomes.

SDG 3 SDG 4

02 Innovations in Chemotherapy and Chemo-radiotherapy +

This session will delve into novel chemotherapy regimens and the integration of chemo-radiotherapy in the treatment of head and neck cancers. Experts will share insights on optimizing treatment protocols to enhance efficacy and minimize toxicity.

SDG 3 SDG 9

03 Clinical Trials in Head and Neck Oncology: Design and Outcomes +

This track will focus on the design, implementation, and outcomes of clinical trials specific to head and neck oncology. Discussions will include challenges faced in recruitment, methodology, and the translation of trial results into clinical practice.

SDG 3 SDG 4

04 Health Economics in Oncology: Cost-Effectiveness and Resource Allocation +

Participants will examine the economic aspects of head and neck cancer treatment, including cost-effectiveness analyses and resource allocation strategies. This track aims to highlight the importance of integrating health economics into clinical decision-making.

SDG 3 SDG 8

05 The Role of HPV in Head and Neck Cancers +

This session will address the epidemiology, pathogenesis, and clinical implications of HPV-related head and neck cancers. Experts will discuss screening, prevention strategies, and the impact of HPV status on treatment outcomes.

SDG 3 SDG 4

06 Surgical Techniques and Reconstruction in Head and Neck Oncology +

This track will focus on innovative surgical techniques and reconstructive strategies for patients with head and neck cancers. Participants will share experiences and outcomes related to complex surgical interventions and their impact on quality of life.

SDG 3 SDG 11

07 Quality of Life and Patient-Centered Outcomes in Oncology +

This session will explore the assessment of quality of life and patient-centered outcomes in individuals diagnosed with head and neck cancers. Discussions will include methodologies for measuring outcomes and the importance of incorporating patient perspectives into care.

SDG 3 SDG 10

08 Radiotherapy Techniques and Advances in Head and Neck Cancer Treatment +

This track will cover the latest advancements in radiotherapy techniques for head and neck cancers, including intensity-modulated radiation therapy and stereotactic body radiotherapy. Participants will discuss the implications of these technologies on treatment efficacy and patient safety.

SDG 3 SDG 9

09 Ethnographic Perspectives in Head and Neck Oncology +

This session will examine the role of ethnography in understanding the cultural and social dimensions of head and neck cancer care. Participants will discuss how ethnographic research can inform practice and improve health disparities among diverse populations.

SDG 10 SDG 16

10 Management of Skin Cancer and Melanoma in the Head and Neck Region +

This track will focus on the unique challenges associated with the diagnosis and management of skin cancer and melanoma in the head and neck region. Experts will discuss treatment options, surgical considerations, and the importance of early detection.

SDG 3 SDG 4

11 Rehabilitation Strategies for Head and Neck Cancer Survivors +

This session will explore rehabilitation approaches for improving function and quality of life in head and neck cancer survivors. Discussions will include speech therapy, nutritional support, and psychosocial interventions to enhance recovery.

SDG 3 SDG 10